Download full report with analyst certification and important disclosures
May 6 2026, 07:29 IST/BST
dsm-firmenich
Q1 EBITDA in line, organic sales growth ahead
- Sectors : Foods
- Companies : dsm-firmenich
DAVY VIEW
dsm-firmenich has delivered a solid start to 2026 with EBITDA in line with expectations. Organic sales growth was well ahead though aided by some pre-buying, notably in Perfumery & Beauty, which delivered a solid underlying performance. Margin in the quarter was dragged down by Taste, Texture & Health. FY guidance was maintained and as such we expect to leave our full year estimates broadly unchanged.
